- Is it possible to build a global company without the United States?
- Is Europe today a safe haven or a regulatory trap?
These questions were raised during Monday's debate (March 24) in Rzeczpospolita, where Maciej Gołaszewski, a Member of the Board at BioCloner Health, participated. During the meeting with leaders of the tech industry, the topic of start-ups and the crisis of globalization was discussed — "How are young innovative companies supposed to operate in the context of closing economies, trade wars, and growing isolationism?"
Such a discussion was truly a valuable experience – not only did it allow for the exchange of various perspectives, but it also created an opportunity to draw important conclusions about the challenges facing young and innovative companies.
The article: https://www.rp.pl/biznes/art42029551-start-upy-w-swiecie-przymknietych-granic